PLUR · Pluri Inc
United States · RS rating 25 · As of 2026-11-03
| Price | 1.27 USD |
|---|---|
| 1-day change | +5.8% |
| RS rating (overall / 1M / 3M / 12M) | 25 / 94 / 23 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 15 / 4 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -9.2% |
| Sales growth Q/Q | -37.3% |
| Distance from 52-week high | +71.5% |
| Market cap (USD) | $34.6M |